MLTX
MoonLake Immunotherapeutics
NASDAQ · Healthcare · Biotechnology · CH
$12.39
+0.32%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.77
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.84
- EPS estimate
- -$0.91
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -5.9%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $40
- PT range
- $29 – $50
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.91 | -$0.84 | Beat 7.55% | — |
| May 11, 2026 | -$0.91 | -$0.98 | Miss -7.69% | — |
| Feb 25, 2026 | -$0.92 | -$0.92 | In line | — |
| Nov 5, 2025 | -$0.89 | -$1.10 | Miss -23.60% | — |
| Feb 26, 2025 | -$0.53 | -$0.72 | Miss -35.85% | $101.8K |
| Nov 7, 2024 | -$0.44 | -$0.56 | Miss -27.27% | — |
| Feb 29, 2024 | -$0.21 | -$0.12 | Beat 42.86% | $19.7K |
| Nov 14, 2023 | -$0.22 | -$0.18 | Beat 18.18% | — |
| Aug 10, 2023 | -$0.25 | -$0.23 | Beat 8.00% | — |
| May 12, 2023 | -$0.28 | -$0.23 | Beat 17.86% | — |
| Mar 20, 2023 | -$0.32 | -$0.31 | Beat 3.13% | — |
| Nov 14, 2022 | -$0.32 | -$0.27 | Beat 15.62% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026